Companies:
49,844
Total Market Cap:
138966323322810.86
Global Rank
#24719
Country Rank
#1543
Market Cap
100.02 M
Price
0.224
Change (%)
4.98%
Volume
1.09 M
Shukra Pharmaceuticals Limited (BOM-524632) Stock Split History
This company has undergone a total of three stock splits throughout its history. Two forward splits were executed, enhancing liquidity and increasing share accessibility. One reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 03/21/2025 with a ratio of 10-for-1. If an investor had purchased one share prior to the first split on 03/10/2014, that single share would now have grown to 1 shares. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| 03/21/2025 | 10:1 | x10 | x1 | Forward |
| 04/19/2024 | 4:1 | x4 | x0.1 | Forward |
| 03/10/2014 | 1:40 | x0.025 | x0.025 | Reverse |
Frequently Asked Questions
-
How much would Shukra Pharmaceuticals Limited stock be worth if it never split?If Shukra Pharmaceuticals Limited (stock symbol: BOM-524632) had never undergone any stock splits, its price per share today would be approximately 0.22 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 10-for-1) that occurred on 03/21/2025.
-
Has Shukra Pharmaceuticals Limited stock ever split?Shukra Pharmaceuticals Limited (stock symbol: BOM-524632) has undergone a total of three stock splits. The most recent split occurred on 03/21/2025. One share bought prior to the first split on 03/10/2014 would now equal 1.00 shares.
-
Will Shukra Pharmaceuticals Limited stock split again?Shukra Pharmaceuticals Limited (stock symbol: BOM-524632) has undergone three stock splits in its history. The most recent split, a 1-for-40 split, occurred on 03/21/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.